TECHNOLOGY LICENSING OPPORTUNITY: Thermostable GlowTag (YFAST)

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

TRIAD - DOE CONTRACTOR

Contract Value

Not provided

Codes & Classification
Solicitation Number

S-167694

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Classification Code

6505

Additional Details
Set Aside

NONE

Place of Performance

Los Alamos, New Mexico, UNITED STATES

SourceSAM
Documents1
The Los Alamos National Laboratory (LANL), operating under the Department of Energy and managed by TRIAD as the DOE contractor, is announcing a technology licensing opportunity for an innovative platform known as the Thermostable GlowTag (YFAST). This special notice, classified under NAICS code 541714 (Research and Development in Biotechnology, except Nanobiotechnology), is not a solicitation for external development services, but rather an invitation for companies to license and commercialize this patented technology. Purpose and Scope: The primary objective of this licensing opportunity is to facilitate the transfer of a novel high-throughput screening technology designed to accelerate the engineering of thermostable enzymes. The technology addresses a critical bottleneck in industrial biotechnology, where the need for enzymes that can withstand high temperatures is paramount for applications such as biofuel production, waste management, chemical and pharmaceutical manufacturing, food and beverage processing, and the textile and detergent industries. Traditional enzymes, typically derived from mesophilic organisms, often lose functionality at elevated temperatures, while naturally thermostable enzymes are rare and challenging to work with. The Thermostable GlowTag (YFAST) system overcomes these limitations by enabling rapid, accurate, and scalable selection of enzyme variants that remain stable and active under heat stress. Key Features and Deliverables: At the core of this innovation is a modified fluorogenic protein, hsFAST, engineered to be stable at high temperatures. Developed using the thermophilic microorganism Parageobacillus thermoglucosidasius as a model, hsFAST emits fluorescence only when properly folded, serving as a direct indicator of enzyme stability and activity. By fusing this thermostable reporter to target enzymes, researchers and developers can visually and quantitatively assess enzyme performance in real time, significantly streamlining the screening and optimization process. The technology offers several key advantages: - Enables rapid, high-throughput screening of enzyme libraries at elevated temperatures. - Utilizes a thermostable fluorogenic reporter for direct, optical quantification of protein expression and stability. - Reduces false positives by employing a direct selection mechanism rather than elimination-based methods. - Facilitates the engineering of mesophilic enzymes for heat resistance, broadening the pool of usable biocatalysts. - Supports the screening and optimization of proteins from both mesophilic and thermophilic sources. - Lowers operational and storage costs by producing enzymes that do not require refrigeration. Intended Outcomes: By licensing this technology, companies can gain a competitive edge in developing robust, cost-effective, and versatile enzymes tailored for demanding industrial and environmental applications. The platform is currently at Technology Readiness Level (TRL) 2-3, with a U.S. non-provisional patent pending (application number 19/284504, reference LA-UR-25-32018). Contracting Entity and Contact Information: The licensing opportunity is managed by the Los Alamos National Laboratory’s Technology Partnerships Office, with the contracting entity being TRIAD, a DOE contractor. The place of performance is Los Alamos, New Mexico, United States. Interested parties are encouraged to contact Caleb Ledgerwood or Lindsay Augustyn at [email protected] for further discussions regarding licensing terms and potential collaboration. Procurement Type and Special Considerations: This notice is issued as a SPECIAL_NOTICE and is not a procurement for goods or services. There are no set-aside requirements associated with this opportunity. The focus is on establishing exclusive or non-exclusive licensing agreements for the commercialization of the technology. Companies of all sizes, including start-ups and established enterprises, are eligible to engage in licensing discussions. Additional Information: LANL’s technology licensing program is dedicated to transitioning laboratory-developed inventions into commercial products, offering a portfolio of patented and patent-pending technologies. More information about the licensing process and available technologies can be found at the following URLs: - https://www.lanl.gov/engage/collaboration/feynman-center/partner-with-us/licensing-technology - https://www.lanl.gov/engage/collaboration/feynman-center/tech-and-capability-search Summary: This active licensing opportunity represents a significant advancement in enzyme engineering, offering a practical solution to longstanding challenges in industrial biotechnology. Companies seeking to enhance their product offerings with robust, thermostable enzymes are encouraged to evaluate this technology for potential integration and commercialization. For further details or to initiate licensing discussions, please contact the LANL Technology Partnerships Office at [email protected]. Notice URL: https://sam.gov/opp/99b177f8d47141d394e223314c7e1194/view